Scrip Asks…What Does 2024 Hold For Biopharma? Part 1: Business Strategy And Leadership
Adapt Around Challenges And Keep The Patient To The Fore
Global crises and a tough funding environment mean biopharma leadership teams need to work hard to survive, let alone thrive. Industry executives shared their predictions and advice on strategy for 2024.
